Literature DB >> 1706611

Distribution of multi-drug resistance-associated P-glycoprotein in normal and neoplastic human tissues. Analysis with 3 monoclonal antibodies recognizing different epitopes of the P-glycoprotein molecule.

P van der Valk1, C K van Kalken, H Ketelaars, H J Broxterman, G Scheffer, C M Kuiper, T Tsuruo, J Lankelma, C J Meijer, H M Pinedo.   

Abstract

P-glycoprotein is a molecule strongly associated with multi-drug resistance to certain cytostatic drugs, including adriamycin, vincristine, and daunorubicin. Using 3 monoclonal antibodies directed at different epitopes of this molecule (JSB-1, MRK16, C219) we investigated the tissue distribution of P-glycoprotein in normal and malignant human tissues, employing a routine immunoperoxidase technique. P-glycoprotein was found in the gastrointestinal epithelium, epithelia of the bronchi, mammary gland, pancreatic ducts, renal tubules, prostate gland, salivary gland, sweat glands of the skin, as well as in bile canaliculi and ductules, the adrenal and in endothelium of capillaries in various organs, most notably the brain. Mostly the pattern of reactivity of the 3 antibodies was similar, but some distinctly different staining reactions were seen. Reactivity was found in a variety of human tumors, arising from tissues normally expressing P-glycoprotein. Knowledge of the distribution and function of this molecule in both normal and malignant tissues may predict resistance and thus may influence choice of therapy. The role of P-glycoprotein in normal tissues and its implications for chemotherapy is discussed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1706611

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


  48 in total

Review 1.  Nanoparticles: a promising modality in the treatment of sarcomas.

Authors:  Michiro Susa; Lara Milane; Mansoor M Amiji; Francis J Hornicek; Zhenfeng Duan
Journal:  Pharm Res       Date:  2010-05-27       Impact factor: 4.200

2.  Vault-related resistance to anticancer drugs determined by the expression of the major vault protein LRP.

Authors:  M A Izquierdo; G L Scheffer; A B Schroeijers; M C de Jong; R J Scheper
Journal:  Cytotechnology       Date:  1998-09       Impact factor: 2.058

Review 3.  The pharmacology of novel oral anticoagulants.

Authors:  Tracy A DeWald; Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2014       Impact factor: 2.300

4.  Broad distribution of the multidrug resistance-related vault lung resistance protein in normal human tissues and tumors.

Authors:  M A Izquierdo; G L Scheffer; M J Flens; G Giaccone; H J Broxterman; C J Meijer; P van der Valk; R J Scheper
Journal:  Am J Pathol       Date:  1996-03       Impact factor: 4.307

5.  Developmental regulation of P-glycoprotein activity within thymocytes results in increased anti-HIV protease inhibitor activity.

Authors:  Soichi Haraguchi; Sarah K Ho; Matthew Morrow; Maureen M Goodenow; John W Sleasman
Journal:  J Leukoc Biol       Date:  2011-04-19       Impact factor: 4.962

Review 6.  Transporter molecules in multidrug resistance.

Authors:  R J Scheper; G L Scheffer; M J Flens; P van der Valk; H J Broxterman; M A Izquierdo
Journal:  Cytotechnology       Date:  1996       Impact factor: 2.058

7.  Tissue distribution of the multidrug resistance protein.

Authors:  M J Flens; G J Zaman; P van der Valk; M A Izquierdo; A B Schroeijers; G L Scheffer; P van der Groep; M de Haas; C J Meijer; R J Scheper
Journal:  Am J Pathol       Date:  1996-04       Impact factor: 4.307

8.  In silico model for P-glycoprotein substrate prediction: insights from molecular dynamics and in vitro studies.

Authors:  Rameshwar Prajapati; Udghosh Singh; Abhijeet Patil; Kailas S Khomane; Pravin Bagul; Arvind K Bansal; Abhay T Sangamwar
Journal:  J Comput Aided Mol Des       Date:  2013-04-24       Impact factor: 3.686

9.  Multidrug resistance gene (P-glycoprotein) expression in the human fetus.

Authors:  C K van Kalken; G Giaccone; P van der Valk; C M Kuiper; M M Hadisaputro; S A Bosma; R J Scheper; C J Meijer; H M Pinedo
Journal:  Am J Pathol       Date:  1992-11       Impact factor: 4.307

10.  Inhibition of ABCB1 (MDR1) expression by an siRNA nanoparticulate delivery system to overcome drug resistance in osteosarcoma.

Authors:  Michiro Susa; Arun K Iyer; Keinosuke Ryu; Edwin Choy; Francis J Hornicek; Henry Mankin; Lara Milane; Mansoor M Amiji; Zhenfeng Duan
Journal:  PLoS One       Date:  2010-05-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.